Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,844 | 31,067 | 36,975 | 53,294 | 11,369 |
| Other current assets | 157 | 316 | 62 | 85 | 97 |
| TOTAL | $29,001 | $31,383 | $37,038 | $53,379 | $11,466 |
| Non-Current Assets | |||||
| PPE Net | 9 | 7 | 8 | 9 | 10 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 48 |
| TOTAL | $9 | $7 | $8 | $9 | $58 |
| Total Assets | $29,010 | $31,390 | $37,046 | $53,389 | $11,524 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,158 | 3,143 | 2,342 | 1,183 | 770 |
| Accrued Expenses | 234 | 710 | 171 | N/A | N/A |
| TOTAL | $3,392 | $3,853 | $2,513 | $1,183 | $770 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,320 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,320 |
| Total Liabilities | $3,392 | $3,853 | $2,513 | $1,183 | $2,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 215 | 208 | 207 | 207 | 207 |
| Common Shares | 13 | 12 | 12 | 12 | 7 |
| Retained earnings | -83,173 | -75,703 | -67,529 | -48,670 | -42,868 |
| TOTAL | $25,619 | $27,537 | $34,533 | $52,205 | $9,434 |
| Total Liabilities And Equity | $29,010 | $31,390 | $37,046 | $53,388 | $11,524 |